Allianz Asset Management GmbH grew its position in Nutrisystem (NASDAQ:NTRI) by 98.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 252,881 shares of the company’s stock after acquiring an additional 125,652 shares during the quarter. Allianz Asset Management GmbH owned about 0.84% of Nutrisystem worth $13,301,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in NTRI. Carillon Tower Advisers Inc. purchased a new position in Nutrisystem during the fourth quarter worth approximately $96,114,000. Wells Fargo & Company MN lifted its position in Nutrisystem by 81.5% during the fourth quarter. Wells Fargo & Company MN now owns 737,760 shares of the company’s stock worth $38,806,000 after buying an additional 331,273 shares in the last quarter. Victory Capital Management Inc. lifted its position in Nutrisystem by 9,342.3% during the fourth quarter. Victory Capital Management Inc. now owns 206,220 shares of the company’s stock worth $10,847,000 after buying an additional 204,036 shares in the last quarter. Point72 Asset Management L.P. lifted its position in Nutrisystem by 1,050.5% during the third quarter. Point72 Asset Management L.P. now owns 209,400 shares of the company’s stock worth $11,705,000 after buying an additional 191,200 shares in the last quarter. Finally, Eagle Asset Management Inc. lifted its position in Nutrisystem by 9.4% during the fourth quarter. Eagle Asset Management Inc. now owns 2,202,208 shares of the company’s stock worth $114,445,000 after buying an additional 189,317 shares in the last quarter.
A number of equities analysts recently commented on the company. DA Davidson reiterated a “buy” rating and set a $80.00 price objective on shares of Nutrisystem in a research report on Friday, December 22nd. Zacks Investment Research upgraded Nutrisystem from a “hold” rating to a “buy” rating and set a $58.00 price objective on the stock in a research report on Tuesday, December 19th. BidaskClub cut Nutrisystem from a “hold” rating to a “sell” rating in a research note on Tuesday, January 23rd. B. Riley set a $52.00 target price on Nutrisystem and gave the stock a “buy” rating in a research note on Thursday, February 22nd. Finally, Barrington Research cut Nutrisystem from an “outperform” rating to a “market perform” rating in a research note on Tuesday, February 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $57.00.
In other news, insider Keira Krausz sold 5,000 shares of Nutrisystem stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $50.96, for a total value of $254,800.00. Following the completion of the sale, the insider now directly owns 75,463 shares of the company’s stock, valued at $3,845,594.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Dawn M. Zier sold 30,825 shares of Nutrisystem stock in a transaction on Monday, February 12th. The shares were sold at an average price of $40.37, for a total value of $1,244,405.25. Following the completion of the sale, the insider now directly owns 221,013 shares of the company’s stock, valued at $8,922,294.81. The disclosure for this sale can be found here. Insiders sold 75,831 shares of company stock valued at $3,566,319 over the last ninety days. Insiders own 2.04% of the company’s stock.
NTRI stock traded up $0.35 during midday trading on Monday, hitting $27.30. 692,198 shares of the company’s stock were exchanged, compared to its average volume of 911,840. The stock has a market cap of $805.52, a price-to-earnings ratio of 13.93, a price-to-earnings-growth ratio of 0.79 and a beta of 1.12. Nutrisystem has a 1-year low of $26.60 and a 1-year high of $67.95.
Nutrisystem (NASDAQ:NTRI) last posted its earnings results on Monday, February 26th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.02. Nutrisystem had a return on equity of 48.69% and a net margin of 8.30%. The company had revenue of $131.20 million during the quarter, compared to analysts’ expectations of $128.75 million. During the same quarter last year, the firm earned $0.29 earnings per share. The firm’s quarterly revenue was up 20.5% compared to the same quarter last year. analysts predict that Nutrisystem will post 2.05 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 19th. Stockholders of record on Thursday, March 8th were paid a $0.25 dividend. The ex-dividend date was Wednesday, March 7th. This is a boost from Nutrisystem’s previous quarterly dividend of $0.18. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.66%. Nutrisystem’s payout ratio is presently 51.02%.
TRADEMARK VIOLATION WARNING: This piece was first published by Enterprise Leader and is the property of of Enterprise Leader. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://theenterpriseleader.com/2018/04/02/allianz-asset-management-gmbh-has-13-30-million-position-in-nutrisystem-nasdaqntri.html.
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.
Receive News & Ratings for Nutrisystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem and related companies with MarketBeat.com's FREE daily email newsletter.